[Observational study of outpatient unit duration of stay depending on the route of administration (intravenous vs subcutaneous) for a targeted therapy]

Bull Cancer. 2017 Oct;104(10):869-874. doi: 10.1016/j.bulcan.2017.08.007. Epub 2017 Oct 13.
[Article in French]

Abstract

New routes of administration available for some targeted therapies, especially subcutaneous injections, have an impact not only on the patients' daycare experience, but also on the unit's organization. This observational study conducted on 48 voluntary patients at the Institut universitaire du cancer Toulouse-Oncopole shows that the mean duration of the outpatient unit stay is diminished by one hour when a subcutaneous injection is used instead of an intravenous route. This duration decrease is mainly caused by an 82% average reduction in treatment duration. However, the waiting times before and after the treatment itself are not significantly impacted. Organizational methods related to the treatment prescription and preparation remain indeed the same. Anticipated prescription is not noticeably impacted either. This reduction of the duration of stay will truly be obtained if the whole unit's organization is adapted.

Keywords: Durée de séjour; Hôpital de jour; Length of stay; Outpatient unit; Route of administration; Voie d’administration.

Publication types

  • Observational Study

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Cancer Care Facilities / organization & administration
  • Cancer Care Facilities / statistics & numerical data
  • Day Care, Medical / organization & administration
  • Day Care, Medical / statistics & numerical data*
  • Drug Compounding / statistics & numerical data
  • Humans
  • Injections, Intravenous / statistics & numerical data
  • Injections, Subcutaneous / statistics & numerical data
  • Length of Stay / statistics & numerical data*
  • Molecular Targeted Therapy / methods*
  • Molecular Targeted Therapy / statistics & numerical data
  • Outpatients
  • Time Factors

Substances

  • Antineoplastic Agents